News

Introducing the NBTS Personalized Support and Navigation Program For years, the National Brain Tumor Society has offered our assistance to patients and caregivers who’ve reached out in need of support, guidance, and/or other resources to help navigate a brain tumor diagnosis and the subsequent treatment experience. While a number of sources for direct patient services exist for brain tumor patients, our new NBTS […] April 17, 2020

Can Newly Approved “Tissue Agnostic” Drugs Benefit Pediatric High-grade Glioma Patients? Recently, the U.S. Food and Drug Administration (FDA) granted accelerated approval* to the drug Rozlytrek (entrectinib, Genentech/Roche**) as a treatment for patients, 12 years or older, whose tumors have a specific genetic defect known as an “NTRK gene fusion.”*** This is now the second drug that the FDA has approved to treat patients with this […] September 16, 2019

Brain Tumor Research Roundup – April 2019 Over the years, NBTS has given nearly $40 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our flagship research projects – like the Defeat GBM (glioblastoma) Research Collaborative – forward, there also continues […] April 24, 2019

For Glioblastoma Immunotherapy, Is Timing Everything? NBTS-funded research shows a significant survival advantage for patients receiving immunotherapy before surgery In recent years, immunotherapy – a treatment strategy to coax the body’s own natural defenses (the immune system) to recognize, target, and destroy tumor cells – has begun to transform cancer research and treatment, stealing headlines along the way. While there are […] February 11, 2019

From the CEO’s Desk: Reflecting on 2018 Greetings and happy holidays to the brain tumor community, Before we turn over a new year, I wanted to take the opportunity to thank our amazing community of supporters, advocates, volunteers, and partners for making 2018 another year of great progress and momentum in the effort to conquer and cure brain tumors. Though we know […] December 27, 2018